Colorectal, Cancer Clinical Trials in Orange, California

8 recruitingOrange, California

Showing 18 of 8 trials

Recruiting
Phase 1Phase 2

A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors

Colorectal, CancerPancreatic CancerMetastatic Solid Tumor+5 more
Frontier Medicines Corporation403 enrolled26 locationsNCT06244771
Recruiting
Phase 1Phase 2

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

Metastatic Breast CancerColorectal, CancerEsophageal Adenocarcinoma+2 more
Boehringer Ingelheim768 enrolled103 locationsNCT06324357
Recruiting
Phase 2

Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial

Breast CancerLiver CancerColorectal, Cancer+7 more
University of California, Irvine24 enrolled1 locationNCT07447050
Recruiting
Phase 1Phase 2

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Colorectal, CancerNon-small Cell Lung Cancer (NSCLC)Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.534 enrolled53 locationsNCT06128551
Recruiting
Phase 1Phase 2

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

Colorectal, CancerEsophageal CancerPancreatic Cancer+3 more
Lantheus Medical Imaging26 enrolled5 locationsNCT06298916
Recruiting
Phase 2

Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Breast CancerLiver CancerColorectal, Cancer+7 more
University of California, Irvine51 enrolled1 locationNCT06580002
Recruiting
Phase 1

Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

Colorectal, CancerColon Adenocarcinoma
University of California, Irvine22 enrolled1 locationNCT04920032
Recruiting

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Triple-Negative Breast CancerColorectal, CancerNon-small Cell Lung Cancer+1 more
Persephone Biosciences5,000 enrolled10 locationsNCT04638751